Aclaris Therapeutics to Attend Upcoming Investor Conferences
August 17 2017 - 8:00AM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led
biopharmaceutical company focused on identifying, developing and
commercializing innovative and differentiated therapies to address
significant unmet needs in medical and aesthetic dermatology, today
announced that members of its management team will present and host
investor meetings at the following upcoming investor events:
- Management will host investor meetings during Citi’s 12th
Annual Biotech Conference in Boston, MA on Wednesday, September 6,
2017.
- Dr. Neal Walker, President and Chief Executive Officer, will
present at the Morgan Stanley 15th Annual Global Healthcare
Conference in New York, NY on Tuesday, September 12, 2017 at 5:15
PM EDT.
- Dr. Walker will also present at the Cantor Fitzgerald Global
Healthcare Conference in New York, NY on Tuesday, September 26,
2017 at 9:10 AM EDT.
A live webcast of the Morgan Stanley 15th Annual Global
Healthcare Conference and the Cantor Fitzgerald Global Healthcare
Conference presentations may be accessed through the Company's web
site, www.aclaristx.com, on the 'Events and Presentations' section.
An archived version of the presentation will be available for 30
days.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a dermatologist-led biopharmaceutical company
focused on identifying, developing and commercializing innovative
and differentiated therapies to address significant unmet needs in
medical and aesthetic dermatology. Aclaris is focused on
large, underserved market segments with no FDA-approved medications
or where treatment gaps exist. Aclaris is based in Malvern,
Pennsylvania and more information can be found by visiting the
Aclaris website at www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Vice President / Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024